ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness
Aberrant activation of the hypoxia-inducible transcription factor HIF-1 and dysfunction of the tumor suppressor p53 have been reported to induce malignant phenotypes and therapy resistance of cancers. However, their mechanistic and functional relationship remains largely unknown. Here, we reveal a m...
| প্রধান লেখক: | , , , , , , , , , , , , , , , , , |
|---|---|
| বিন্যাস: | Journal article |
| ভাষা: | English |
| প্রকাশিত: |
EMBO Press
2022
|
| _version_ | 1826315133242048512 |
|---|---|
| author | Koyasu, S Horita, S Saito, K Kobayashi, M Ishikita, H Chow, CC Kambe, G Nishikawa, S Menju, T Morinibu, A Okochi, Y Tabuchi, Y Onodera, Y Takeda, N Date, H Semenza, GL Hammond, EM Harada, H |
| author_facet | Koyasu, S Horita, S Saito, K Kobayashi, M Ishikita, H Chow, CC Kambe, G Nishikawa, S Menju, T Morinibu, A Okochi, Y Tabuchi, Y Onodera, Y Takeda, N Date, H Semenza, GL Hammond, EM Harada, H |
| author_sort | Koyasu, S |
| collection | OXFORD |
| description | Aberrant activation of the hypoxia-inducible transcription factor HIF-1 and dysfunction of the tumor suppressor p53 have been reported to induce malignant phenotypes and therapy resistance of cancers. However, their mechanistic and functional relationship remains largely unknown. Here, we reveal a mechanism by which p53 deficiency triggers the activation of HIF-1-dependent hypoxia signaling and identify zinc finger and BTB domain-containing protein 2 (ZBTB2) as an important mediator. ZBTB2 forms homodimers via its N-terminus region and increases the transactivation activity of HIF-1 only when functional p53 is absent. The ZBTB2 homodimer facilitates invasion, distant metastasis, and growth of p53-deficient, but not p53-proficient, cancers. The intratumoral expression levels of ZBTB2 are associated with poor prognosis in lung cancer patients. ZBTB2 N-terminus-mimetic polypeptides competitively inhibit ZBTB2 homodimerization and significantly suppress the ZBTB2-HIF-1 axis, leading to antitumor effects. Our data reveal an important link between aberrant activation of hypoxia signaling and loss of a tumor suppressor and provide a rationale for targeting a key mediator, ZBTB2, to suppress cancer aggressiveness. |
| first_indexed | 2024-12-09T03:20:20Z |
| format | Journal article |
| id | oxford-uuid:749c9c4d-7e64-45aa-8a6c-cbb77affb06c |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-12-09T03:20:20Z |
| publishDate | 2022 |
| publisher | EMBO Press |
| record_format | dspace |
| spelling | oxford-uuid:749c9c4d-7e64-45aa-8a6c-cbb77affb06c2024-11-11T10:46:00ZZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressivenessJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:749c9c4d-7e64-45aa-8a6c-cbb77affb06cEnglishSymplectic ElementsEMBO Press2022Koyasu, SHorita, SSaito, KKobayashi, MIshikita, HChow, CCKambe, GNishikawa, SMenju, TMorinibu, AOkochi, YTabuchi, YOnodera, YTakeda, NDate, HSemenza, GLHammond, EMHarada, HAberrant activation of the hypoxia-inducible transcription factor HIF-1 and dysfunction of the tumor suppressor p53 have been reported to induce malignant phenotypes and therapy resistance of cancers. However, their mechanistic and functional relationship remains largely unknown. Here, we reveal a mechanism by which p53 deficiency triggers the activation of HIF-1-dependent hypoxia signaling and identify zinc finger and BTB domain-containing protein 2 (ZBTB2) as an important mediator. ZBTB2 forms homodimers via its N-terminus region and increases the transactivation activity of HIF-1 only when functional p53 is absent. The ZBTB2 homodimer facilitates invasion, distant metastasis, and growth of p53-deficient, but not p53-proficient, cancers. The intratumoral expression levels of ZBTB2 are associated with poor prognosis in lung cancer patients. ZBTB2 N-terminus-mimetic polypeptides competitively inhibit ZBTB2 homodimerization and significantly suppress the ZBTB2-HIF-1 axis, leading to antitumor effects. Our data reveal an important link between aberrant activation of hypoxia signaling and loss of a tumor suppressor and provide a rationale for targeting a key mediator, ZBTB2, to suppress cancer aggressiveness. |
| spellingShingle | Koyasu, S Horita, S Saito, K Kobayashi, M Ishikita, H Chow, CC Kambe, G Nishikawa, S Menju, T Morinibu, A Okochi, Y Tabuchi, Y Onodera, Y Takeda, N Date, H Semenza, GL Hammond, EM Harada, H ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness |
| title | ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness |
| title_full | ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness |
| title_fullStr | ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness |
| title_full_unstemmed | ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness |
| title_short | ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness |
| title_sort | zbtb2 links p53 deficiency to hif 1 mediated hypoxia signaling to promote cancer aggressiveness |
| work_keys_str_mv | AT koyasus zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT horitas zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT saitok zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT kobayashim zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT ishikitah zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT chowcc zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT kambeg zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT nishikawas zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT menjut zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT morinibua zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT okochiy zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT tabuchiy zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT onoderay zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT takedan zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT dateh zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT semenzagl zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT hammondem zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness AT haradah zbtb2linksp53deficiencytohif1mediatedhypoxiasignalingtopromotecanceraggressiveness |